Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities.

The synthesis of a new series of abacavir prodrugs involving N2-substitution with various substituted benzaldehyde and ketone derivatives is described. The in vitro anti-HIV activities indicated that compound (3-(2-(4-methylaminobenzylideneamino)-6-(cyclopropylamino)-9H-purin-9-yl)cyclopentyl)methanol (3) was found to be most potent compound with EC50 of 0.05 microM and CC50 of >100 microM with selectivity index of >2000. Compound 3 was found to be 32 times more potent than the parent drug (EC50 of 1.6 microM). At pH 7.4, 37 degrees C, the hydrolytic t1/2 ranged between 120 and 240 min.

[1]  W H Oldendorf,et al.  Lipid Solubility and Drug Penetration of the Blood Brain Barrier , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  H. Bundgaard,et al.  Prodrugs of Peptides. 6. Bioreversible Derivatives of Thyrotropin-Releasing Hormone (TRH) with Increased Lipophilicity and Resistance to Cleavage by the TRH-Specific Serum Enzyme , 1990, Pharmaceutical Research.

[3]  K. Agrawal,et al.  Synthesis and biological evaluation of prodrugs of zidovudine. , 1990, Journal of medicinal chemistry.

[4]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[5]  D. Jeffries,et al.  Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity. , 1990, Antiviral research.

[6]  H. Mitsuya,et al.  Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. , 1991, Journal of medicinal chemistry.

[7]  P. Yogeeswari,et al.  Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: hybrid pharmacophore-based design. , 2005, Journal of medicinal chemistry.

[8]  H. Bundgaard,et al.  Kinetics and Pattern of Degradation of Thyrotropin-Releasing Hormone (TRH) in Human Plasma , 1990, Pharmaceutical Research.

[9]  E. De Clercq,et al.  Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency. , 2005, Journal of medicinal chemistry.

[10]  P. Yogeeswari,et al.  Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. , 2005, European journal of medicinal chemistry.

[11]  P. Yogeeswari,et al.  Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. , 2004, Bioorganic & medicinal chemistry letters.

[12]  P. Yogeeswari,et al.  Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  M. Boyd,et al.  New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. , 1989, Journal of the National Cancer Institute.

[14]  R. Schinazi,et al.  Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine. , 1990, Journal of medicinal chemistry.